In response to a request from APC and NCPA, FDA’s Center for Veterinary Medicine last week issued a Letter to Industry explaining the phased-in approach to enforcement the agency plans to take on GFI 256.
The Prescriber Briefs developed by APC and the Pharmacy Compounding Foundation are excellent resources for educating prescribers about pharmacy compounding—including laws, guidance, and standards you must adhere to.
Since the program’s inception, 112 pharmacists have been nominated to this elite group. Thirteen new members were inducted during last year's Compounders on Capitol Hill.
In advance of the Apr 1, 2023, enforcement date for the new animal compounding guidance from FDA, APC and PCCA are partnering to offer a CE webinar aimed at helping you bring your animal compounding operations into compliance.
APC's new Prescriber Brief was designed to help you coach the veterinarians you work with on what they must document on prescriptions for compounded animal drugs.
We have a choice. To sit on the sidelines and let others determine our fate. Or get into the fight and tell our own story.
APC has an extensive library of on-demand webinars available—including EduCon 2023—for you to access whenever and wherever.
Over the past two years, The Townsend Letter has partnered with APC to alert prescribers and others about the threat to restrict compounded hormone therapy.
DEA's new proposed rule could affect compounded testosterone.
Here’s some good news: We’ve managed to buy you a few extra days to take advantage of our reduced hotel room rate for the conference. The new cutoff for special rates at Marriott’s Grand Hotel is NOW Tuesday, March 7.
FOLLOW US
